cancer research

Cancer Research UK has launched its Grand Challenge: «the most ambitious cancer research grants in the world», worth up to £20 million (about €27 million) each. They’re intended to catalyse a revolution in how we prevent, diagnose, and treat cancer by bringing together the brightest minds around the globe, providing the freedom to undertake innovative, game-changing research.

IPO- Lisboa, Lisbon, Portugal

5 November, 2015

See more informations here: http://in3.dem.ist.utl.pt/events.asp?EventsID=157

IPO- Lisboa, Lisbon, Portugal

5 November, 2015

See more informations here: http://in3.dem.ist.utl.pt/events.asp?EventsID=157

Manchester Central Convention Complex, Manchester, United Kingdom

9 - 12 July, 2016

See more informations here: http://eacr24.eacr.org/

Manchester Central Convention Complex, Manchester, United Kingdom

9 - 12 July, 2016

See more informations here: http://eacr24.eacr.org/

How to proceed towards an European cancer institute - a complex process under discussion: http://www.cancerworld.org/pdf/8783_pagina_42_45_Spotlight_On.pdf

How to proceed towards an European cancer institute - a complex process under discussion: http://www.cancerworld.org/pdf/8783_pagina_42_45_Spotlight_On.pdf

Belgrade, Serbia

02 - 03 October,  2015

See more informations here: http://www.sdir.ac.rs/en/

Belgrade, Serbia

02 - 03 October,  2015

See more informations here: http://www.sdir.ac.rs/en/

Recently, the Portuguese press announced in several front pages that a private Foundation (Fundação Champalimaud) was capable to cure 90% of cancer patients with single dose radiotherapy. This announcement was very unfortunate. It is obviously a false statement from the professionals and scientists standpoint, but not for patients. Patients and their families tend to invest their expectations in whatever promise, even if the “good news” may sound as suspicious to everybody that is not sufficiently acquainted with science progress (and limitations).